Leap Therapeutics Stock Widgets and Gadgets
| LPTX Stock | USD 2.91 0.02 0.69% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- LPTX Leap Therapeutics
- Latest Leap Therapeutics to Participate at Piper Sandler 36th Annual Healthcare Conference
- LPTX 2.91 0.02
- Low 2.83
- High 2.94
- Volume 22.1 K
- Alpha 0.17
- Beta 1.41
- Return On Equity -0.81
- Return On Asset -0.46
- Current Valuation 48.29 M
- Shares Outstanding 38.32 M
- Shares Owned By Insiders 17.28 %
- Shares Owned By Institutions 40.30 %
- Number Of Shares Shorted 1.42 M
- Price To Earning (1.85) X
- Price To Book 2.26 X
- Price To Sales 160.10 X
- Gross Profit 1.5 M
- EBITDA (80.99 M)
- Net Income (81.41 M)
- Cash And Equivalents 90.88 M
- Cash Per Share 0.92 X
- Total Debt 262 K
- Debt To Equity 0.01 %
- Current Ratio 8.88 X
- Book Value Per Share 2.35 X
- Cash Flow From Operations (43.75 M)
- Short Ratio 2.68 X
- Earnings Per Share (1.64) X
- Price To Earnings To Growth 0.75 X
- Target Price 11.38
- Number Of Employees 54
- Beta 0.22
- Market Capitalization 111.51 M
- Total Asset 72.83 M
- Retained Earnings (399.58 M)
- Working Capital 58.91 M
- Current Asset 2.38 M
- Current Liabilities 22.01 M
- Net Asset 72.83 M
- Accumulation Distribution 826.12
- Daily Balance Of Power 0.1818
- Rate Of Daily Change 1.01
- Day Median Price 2.89
- Day Typical Price 2.89
- Price Action Indicator 0.035
- Period Momentum Indicator 0.02
Market Snapshot Widget Example
DAX Index Germany | 19,849 0.18 | |
Taiwan Weighted Taiwan | 23,120 0.07 | |
PSI 20 Stock Portugal | 6,326 0.32 | |
CROBEX Croatia | 3,204 0.17 | |
Budapest SE Hungary | 79,493 0.95 | |
IDX 30 Jakarta Indonesia | 424.36 0.55 | |
ISEQ 20 Price Ireland | 1,631 0.42 | |
NYSE Comp USA | 19,341 0.70 | |
Tel Aviv 35 Israel | 2,403 0.61 | |
Coreshares Index Tracker South Afric | 1,128 1.26 | |
IPC MEXICO Mexico | 49,317 0.59 | |
KL Technology Malaysia | 64.10 0.12 | |
IBEX 35 Index Spain | 11,474 0.33 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,607 0.50 | |
SPASX Dividend Opportunities Australia | 1,660 0.16 | |
HNX 30 Vietnam | 482.72 0.42 | |
Bucharest BET-NG Romania | 1,214 0.52 | |
AMS Small Cap Netherlands | 1,248 0.89 | |
Oslo Exchange Mutual Norway | 1,367 0.54 | |
BEL Small Belgium | 8,217 1.09 | |
Basic Materials Brazil | 5,571 0.52 | |
Swiss Leader Price Switzerland | 1,900 0.84 | |
Fondo Mutuo ETF Chile | 1,388 0.27 | |
Athens General Comp Greece | 1,449 0.25 | |
Stock Exchange Of Thailand | 1,395 0.56 | |
PX Prague Stock Czech Repub | 1,762 0.41 | |
THE PHILIPPINE STOCK Philippines | 6,535 2.01 | |
WIG 30 Poland | 2,814 0.13 | |
BIST Electricity Turkey | 498.04 0.21 |
Investing Ideas
In addition to having Leap Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Leap Therapeutics
Compare Leap Therapeutics To Peers
Additional Tools for Leap Stock Analysis
When running Leap Therapeutics' price analysis, check to measure Leap Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Leap Therapeutics is operating at the current time. Most of Leap Therapeutics' value examination focuses on studying past and present price action to predict the probability of Leap Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Leap Therapeutics' price. Additionally, you may evaluate how the addition of Leap Therapeutics to your portfolios can decrease your overall portfolio volatility.